MilliporeSigma
  • Home
  • Search Results
  • Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.

Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.

Journal of lipid research (2015-02-04)
Mohamad Navab, Arnab Chattopadhyay, Greg Hough, David Meriwether, Spencer I Fogelman, Alan C Wagner, Victor Grijalva, Feng Su, G M Anantharamaiah, Lin H Hwang, Kym F Faull, Srinivasa T Reddy, Alan M Fogelman
ABSTRACT

We previously reported that i) a Western diet increased levels of unsaturated lysophosphatidic acid (LPA) in small intestine and plasma of LDL receptor null (LDLR(-/-)) mice, and ii) supplementing standard mouse chow with unsaturated (but not saturated) LPA produced dyslipidemia and inflammation. Here we report that supplementing chow with unsaturated (but not saturated) LPA resulted in aortic atherosclerosis, which was ameliorated by adding transgenic 6F tomatoes. Supplementing chow with lysophosphatidylcholine (LysoPC) 18:1 (but not LysoPC 18:0) resulted in dyslipidemia similar to that seen on adding LPA 18:1 to chow. PF8380 (a specific inhibitor of autotaxin) significantly ameliorated the LysoPC 18:1-induced dyslipidemia. Supplementing chow with LysoPC 18:1 dramatically increased the levels of unsaturated LPA species in small intestine, liver, and plasma, and the increase was significantly ameliorated by PF8380 indicating that the conversion of LysoPC 18:1 to LPA 18:1 was autotaxin dependent. Adding LysoPC 18:0 to chow increased levels of LPA 18:0 in small intestine, liver, and plasma but was not altered by PF8380 indicating that conversion of LysoPC 18:0 to LPA 18:0 was autotaxin independent. We conclude that i) intestinally derived unsaturated (but not saturated) LPA can cause atherosclerosis in LDLR(-/-) mice, and ii) autotaxin mediates the conversion of unsaturated (but not saturated) LysoPC to LPA.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Stearic acid, Grade I, ≥98.5% (capillary GC)
Sigma-Aldrich
Oleic acid, suitable for cell culture, BioReagent
Sigma-Aldrich
Oleic acid, ≥99% (GC)
Sigma-Aldrich
Oleic acid, meets analytical specification of Ph, Eur., 65.0-88.0% (GC)
Sigma-Aldrich
Stearic acid, reagent grade, 95%
Sigma-Aldrich
Oleic acid, technical grade, 90%
Sigma-Aldrich
Stearic acid, ≥95%, FCC, FG
Sigma-Aldrich
Oleic acid, natural, FCC
Supelco
Stearic acid, analytical standard
Supelco
Oleic acid, analytical standard
Stearic acid, European Pharmacopoeia (EP) Reference Standard
Supelco
Oleic acid, Selectophore, ≥99.0%
Supelco
Stearic Acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Stearic acid, certified reference material, TraceCERT®
USP
Stearic acid, United States Pharmacopeia (USP) Reference Standard
Supelco
Melting Point Standard 69-71°C, analytical standard
Oleic acid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Palmitic acid, ≥95%, FCC, FG
Supelco
Palmitic acid, analytical standard
Sigma-Aldrich
Palmitic acid, ≥98% palmitic acid basis (GC)
Sigma-Aldrich
Palmitic acid, BioXtra, ≥99%
Sigma-Aldrich
Palmitic acid, ≥99%
Sigma-Aldrich
Linoleic acid, liquid, BioReagent, suitable for cell culture
Sigma-Aldrich
Linoleic acid, ≥99%
Supelco
Linoleic acid, analytical standard
Sigma-Aldrich
Linoleic acid, technical, 58-74% (GC)
Sigma-Aldrich
Palmitic acid, natural, 98%, FG
Supelco
Palmitic acid, certified reference material, TraceCERT®
Supelco
Palmitic acid, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Palmitic acid, United States Pharmacopeia (USP) Reference Standard